2.其他需要提示的事项 1.公告基本信息 ■ 广发基金管理有限公司（以下简称"本公司"）决定自2025年8月1日起，广发聚财信用债券型证券投资基 金（以下简称"本基金"）调整投资者单日单个基金账户申购（含定期定额和不定额投资）及转换转入本 基金的业务限额为30,000,000.00元。即如投资者单日单个基金账户申购（含定期定额和不定额投资）及 转换转入本基金的申请金额大于30,000,000.00元，则30,000,000.00元确认成功，超过30,000,000.00元 （不含）金额的部分将有权确认失败；如投资者单日单个基金账户多笔累计申购（含定期定额和不定额 投资）及转换转入本基金的金额大于30,000,000.00元，按申请金额从大到小排序，本公司将逐笔累加至 30,000,000.00元的申请确认成功，其余超出部分的申请金额本公司有权确认失败。 投资者通过多家销售渠道的多笔申购（含定期定额和不定额投资）及转换转入申请将累计计算，不同份 额的申请将单独计算限额，并按上述规则进行确认。 如有疑问，请拨打本公司客户服务热线95105828或020-83936999，或登录本公司网站 www.gffunds. ...

Group 1 - The core point of the article highlights the performance and holdings of the GF Healthcare Stock A fund, which has shown significant returns over various time frames [1] - As of June 30, 2025, the fund's total assets amount to 5.247 billion yuan, with a recent net value of 2.1160 yuan, reflecting a decrease of 0.92% [1] - The fund's performance over the past month, six months, and year-to-date shows returns of 13.92%, 33.38%, and 30.91% respectively, with rankings of 87 out of 725, 67 out of 709, and 86 out of 705 in their respective categories [1] Group 2 - The top ten holdings of the GF Healthcare Stock A fund account for a total of 50.56%, with the largest positions in companies such as Zai Lab (9.36%) and Kelun Pharmaceutical (8.62%) [1] - The fund manager, Wu Xingwu, has extensive experience in the investment management field, having managed multiple funds since 2015 and currently overseeing several healthcare-related funds [2]

Group 1 - Several securities firms, including CITIC Securities and Guosen Securities, have quickly launched trading permissions for the new Sci-Tech Growth Board, indicating high market interest in this new segment [1] - Investors need to meet a threshold of 500,000 yuan in assets and have two years of investment experience to participate, which helps filter qualified investors and manage risks [1] - The introduction of the Sci-Tech Growth Board enhances the multi-tiered capital market structure, providing financing channels for tech innovation companies, which is expected to boost overall market vitality and innovation momentum in the long term [1] Group 2 - On July 29, Founder Securities announced that its major shareholder, China Cinda Asset Management, did not execute its planned share reduction, which is seen as a positive signal for the company's long-term value [2] - The unchanged shareholding of China Cinda, which holds 593 million shares (7.2% of total shares), may help stabilize market sentiment and alleviate investor concerns about share dilution [2] - This situation is likely to support the brokerage sector and enhance confidence in financial stocks, contributing to market stability [2] Group 3 - In July, over 900 billion yuan worth of new funds were issued, indicating a recovery in market confidence [3] - The increase in stock and bond fund shares, driven by the equity market and innovative products like the Sci-Tech Bond ETF, reflects a growing risk appetite among investors [3] - The decline in mixed fund shares suggests a preference for clearer directional investments, which may lead to increased activity in related sectors and improved market liquidity [3] Group 4 - Seven ETFs have achieved "doubling" performance this year, with the top performer, Huatai-PB Hang Seng Innovation Drug ETF, showing a 107.67% return [4] - The strong performance of Hong Kong innovation drug ETFs highlights the robust market interest in the innovative drug sector, potentially attracting more capital into the healthcare segment [4] - Continued advancements in innovative drug research and supportive policies are key drivers for the pharmaceutical industry, with high-performing ETFs likely to enhance investor risk appetite [4]

Core Viewpoint - Guangdong Construction Group has experienced a decline in stock price over the past five trading days, with a cumulative drop of -9.22% [1] Group 1: Company Overview - Guangdong Construction Group Co., Ltd. was established in 2001 and is the only publicly listed construction company controlled by the Guangdong Provincial Government [1] - The company is primarily controlled by Guangdong Provincial Construction Engineering Group Co., Ltd. [1] Group 2: Financial Performance - The financial report indicates that GF Fund's Guangfa CSI Infrastructure Engineering ETF is among the top ten shareholders of Guangdong Construction, which reduced its holdings in the first quarter of this year [1] - The year-to-date return for the ETF is 4.69%, ranking 2916 out of 3381 in its category [1][2] Group 3: Market Comparison - The ETF's performance over various periods shows a near-term decline of -2.54% over the past week, but a positive return of 9.87% over the past month and 12.87% over the past three months [2] - In comparison, the average return for similar funds is 11.94% year-to-date, indicating that Guangdong Construction's performance is lagging behind its peers [2]

Report Industry Investment Rating No relevant content provided. Core Viewpoints - In the week from July 21 - 25, 2025, the bond market adjusted. The net value of benchmark market - making credit bond ETFs and science - innovation bond ETFs declined significantly, and the overall net subscription of science - innovation bonds was 5.56 billion yuan. Institutions may have redeemed ETF shares to cope with liquidity shocks [4]. - After the adjustment, some science - innovation bonds have fallen to a point where they offer value. For allocation portfolios, some exchange - traded science - innovation bonds with a remaining term of 4 - 5 years are worth considering; for trading portfolios, short - term index component science - innovation bonds are more attractive [4]. - The science - innovation bond ETF is expected to expand further. After the adjustment, index component science - innovation bonds with a widening relative spread have certain value, and investors can participate at the current adjusted points and wait for the spread to recover [46]. Summary by Directory I. First Batch of Science - Innovation Bond ETFs Expanded Rapidly in One Week after Listing - On July 17, 2025, 10 science - innovation bond ETFs were listed. By July 25, the total scale exceeded 100 billion yuan, with a growth rate of over 250% [15]. - The 10 products were all raised on July 7, 2025, and the total raised scale was about 29 billion yuan, indicating strong market demand [15]. - There are differences in product elements such as redemption methods, product durations, and component bond capacities among these 10 science - innovation bond ETFs [20]. II. Index Component Bonds of Science - Innovation Bond ETFs Led the Decline in this Adjustment - In terms of net value fluctuations, the net value of benchmark market - making credit bond ETFs and science - innovation bond ETFs declined by about 0.3% in a week [29]. - In terms of subscription and redemption data, the overall net subscription of science - innovation bonds was 5.56 billion yuan, while short - term financing ETFs and benchmark market - making credit bond ETFs with good liquidity were more affected by redemptions, suggesting that institutions may have redeemed shares for liquidity reasons [4]. - In terms of the performance of underlying component bonds, science - innovation bond index component bonds had a faster adjustment speed and a larger adjustment range. Exchange - traded non - science - innovation index component science - innovation bonds and inter - bank science - innovation bonds were relatively more resilient [35]. III. Which Science - Innovation Bonds Have Fallen to an Attractive Level? - After the adjustment, the overall yield of science - innovation bonds increased, and the inversion between the average valuation of short - term component bonds and the 1 - year AAA certificate of deposit yield improved significantly. However, the yields of 1 - year - below and 1 - 2 - year science - innovation bond index component bonds of AAA grade were still 1 - 2 BP lower than the 1 - year AAA certificate of deposit yield [39]. - The relative spread between exchange - traded and inter - bank science - innovation bonds of the same issuer showed differentiation. Index component science - innovation bonds with a widening relative spread have certain value, and investors can participate at the current adjusted points [44]. - For allocation portfolios, some exchange - traded science - innovation bonds with a remaining term of 4 - 5 years are worth considering due to the relatively large increase in valuation compared to their inter - bank counterparts and the attractive static coupon income [46]. - For trading portfolios, it is more advisable to focus on 1 - 2 - year index component science - innovation bonds that have adjusted significantly, have a large outstanding scale, and a valuation higher than 1.67% [49].

Company Overview - Henan Ruibeka Hair Products Co., Ltd. is located in Yichang, Henan Province, and was established in 1990 as Xuchang Hair Products Factory, later becoming a joint venture in 1993 and officially listed on the Shanghai Stock Exchange in 2003 [1] Shareholder Information - GF Fund's Guangfa Pension Index A is among the top ten shareholders of Ruibeka, having increased its stake to 0.33% in the first quarter of this year [1] - The fund has achieved a year-to-date return of 7.97%, ranking 1716 out of 3052 in its category [2] Fund Performance - The performance metrics for Guangfa Pension Index A show a weekly increase of 1.33%, a monthly increase of 3.33%, a quarterly increase of 8.81%, a six-month increase of 12.12%, and a year-to-date increase of 7.97% [2] - The average performance of similar funds is higher, with a year-to-date return of 11.66% [2] Fund Management - The fund manager for Guangfa Pension Index A is Mr. Cao Shiyu, who has been with GF Fund since June 2014 and has held various research and management roles [4][5]

Group 1 - The core viewpoint of the report indicates that the construction materials and coal industries performed well during the period, with the Shanghai Composite Index rising by 1.67% and the Shenzhen Component Index increasing by 2.33% [2][9] - In the recent 12 periods, the comprehensive and pharmaceutical industries showed strong performance, suggesting potential investment opportunities in these sectors [9] - Active equity funds focusing on electronics and coal industries also demonstrated superior performance during this period [14] Group 2 - Among various fund types, actively managed stock funds increased by 1.55%, while mixed funds rose by 1.63%, and bond funds saw a slight decline of 0.16% [2] - The average return of convertible bond funds was notably high at 12.46% year-to-date, indicating a strong performance in this category [17] - QDII funds, particularly those focused on Asia-Pacific and emerging markets, led the performance with an increase of 2.56% during the period [19][21]

Core Viewpoint - Multiple funds have issued premium risk alerts, particularly QDII funds, indicating a significant increase in premium risk notifications since July, with a notable impact on investor decisions [1][3]. Group 1: Premium Risk Alerts - As of July 28, five funds issued premium risk alerts, contributing to over 70 notifications in July alone, with six out of ten being QDII funds [1][3]. - The Guotai S&P 500 ETF (QDII) and the Invesco Great Wall S&P Consumer ETF (QDII) have issued 21 premium risk alerts since July [1][3]. - The premium rates for the aforementioned funds reached 7.95% and 20.64% respectively as of July 28 [3]. Group 2: Market Performance and Fund Returns - The three major U.S. stock indices have shown year-to-date gains of 5.54%, 9.31%, and 8.62% respectively [4]. - The performance of QDII funds has been notable, with the Huatai-PineBridge Hong Kong Advantage Selected Mixed Fund (QDII) achieving a year-to-date return of 135.58%, ranking first among all market products [4]. - Other QDII funds in the healthcare and innovation sectors have also reported year-to-date returns exceeding 80% [4]. Group 3: Market Valuation and Investment Considerations - The forward P/E ratio of the S&P 500 index has reached 23.3, indicating limited valuation attractiveness [5]. - Market analysts suggest that while the U.S. market may continue to trend upward, uncertainties remain, and significant investments should be approached with caution due to high premium risks [5]. - Investors are advised to monitor premium rates closely, with alerts for rates exceeding 5% and heightened caution for rates above 10% due to potential liquidity risks [5].

Group 1 - The core point of the article highlights the performance and holdings of the Guangfa Healthcare Stock A fund, which has a recent net value of 2.0420 yuan, reflecting a decline of 1.11% [1] - The fund has shown a one-month return of 9.31%, ranking 210 out of 1027 in its category, a six-month return of 28.71%, ranking 96 out of 999, and a year-to-date return of 26.33%, ranking 124 out of 989 [1] - The top ten holdings of the fund account for a total of 50.56%, with significant positions in companies such as Zai Lab (9.36%), Kelun Pharmaceutical (8.62%), and Bai Li Tianheng (7.47%) [1] Group 2 - Guangfa Healthcare Stock A fund was established on August 10, 2017, and as of June 30, 2025, it has a total scale of 5.247 billion yuan [1] - The fund is managed by Wu Xingwu, who has extensive experience in the investment management field, having held various positions in Guangfa Fund Management and other financial institutions [2]

首批21家机构入选网下专业机构投资者 "白名单" 智通财经7月25日电，中证协发布2024年网下专业机构投资者 "白名单"，共有首批21家网下专业机构投 资者纳入"白名单"。包括博时基金、大成基金、富国基金、广发基金、国泰基金、华安基金、华泰资 管、汇添富基金、交银施罗德基金、景顺长城基金、南方基金、平安资管、睿远基金、东方证券资管、 泰康资管、银华基金、招商基金、中金公司、人寿养老保险、中欧基金、中信证券。中证协将对纳 入"白名单"网下投资者采取激励措施，例如开通网下投资者注册绿色通道，供相关监管部门、自律组织 等在分类监管、自律管理等工作中参考使用。（智通财经记者 林坚） | | 2024年网下专业机构投资者"白名单" | | --- | --- | | 序号 | 网下投资者名称 | | 1 | 博时喜美最插掉限公司 | | 2 | 大成基金管理有限公司 | | 3 | 富国墓会管理有限公司 | | 4 | 广发基金管理有限公司 | | 5 | 国泰基金管理有限公司 | | 6 | 华安基金管理有限公司 | | 7 | 华泰资产管理有限公司 | | 8 | 汇添富基金管理股份有限公司 | | 9 | 交银 ...